Test Price
2,800 AED✅ Home Collection Available
ACADS Gene (Acyl-CoA Short-Chain Dehydrogenase Deficiency) Genetic Test in UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited next-generation sequencing (NGS) processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic post-test clinical guidance for result interpretation provided by our Consultant Medical Genetics.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Certification: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | DHA Licensed Facility No. 1143.
Test Overview & Methodology
The ACADS gene test identifies mutations causing short-chain acyl-CoA dehydrogenase deficiency (SCADD), an inherited metabolic disorder impairing fatty acid oxidation. This NGS-based analysis offers comprehensive sequencing of the entire ACADS gene to guide diagnosis, dietary management, and family planning. The methodology uses Illumina® platform with Sanger confirmation for all detected variants, ensuring >99.9% analytical sensitivity for single nucleotide variants, indels, and copy number changes.
| Parameter | Our Test (NGS – Next‑Generation Sequencing) | Closest Alternative (Biochemical Enzyme Assay / Targeted Mutation Panel) |
|---|---|---|
| Precision | >99.9% analytical sensitivity for single nucleotide variants, indels, and copy number changes across the entire ACADS gene | May miss deep intronic or novel variants; enzyme assay can be influenced by metabolic state |
| Method | Full gene sequencing by NGS (Illumina® platform), confirmed by Sanger sequencing if needed | Spectrophotometric enzyme activity assay or limited mutation hotspot panel |
| Turnaround Time | 3–4 Weeks with secure online report | 4–6 Weeks (enzyme assay); faster for targeted panels but less comprehensive |
Physician Insight & Safety Protocols
I understand that facing a potential metabolic diagnosis can be worrying. This genetic test provides crucial insights, but a complete clinical picture requires evaluation of symptoms, diet history, and enzyme activity. Please remember that a definitive diagnosis should be made in partnership with your specialist, and genetic counselling is strongly recommended.
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Medical Advisory
Do not discontinue prescribed medication without consulting your doctor.
Always seek professional medical advice before altering any treatment regimen. This test is for diagnostic guidance and is not a substitute for ongoing medical care.
Exclusion Criteria & Emergency Red Flags
- Patients unable to provide informed consent (legal guardian required for minors, in compliance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Recent blood transfusion (within 2 weeks) may affect sample quality; pre-test genetic counselling appointment is mandatory to draw a pedigree chart of family members affected with short-chain acyl-CoA dehydrogenase deficiency.
Emergency Red Flags (seek immediate medical attention):
- Acute vomiting, severe lethargy, unexplained hypoglycemia, seizures, or coma – do not rely solely on this genetic test result in an emergency.
Patient FAQ & Clinical Guidance
1. What is the ACADS gene test and why is it performed?
This NGS test identifies ACADS gene mutations responsible for short-chain acyl-CoA dehydrogenase deficiency, a metabolic disorder. It helps confirm the diagnosis, guide dietary management, and enable family planning decisions.
2. How is the sample collected and what is the turnaround time?
A blood sample is collected via our VIP Mobile Phlebotomy service at your home or preferred location, ensuring hospital-grade standards. NGS analysis delivers results within 3 to 4 weeks via a secure online report.
3. Does insurance cover the ACADS gene test?
We offer direct insurance billing verification for most UAE health plans. Contact us via WhatsApp at +971 54 548 8731 with your policy details for a rapid pre‑approval check.
UAE Regulatory & Data Privacy Adherence
Data Protection: All personal and genetic data is handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient confidentiality is maintained through encrypted storage and restricted access protocols.
Laboratory Licensing: DNA Labs UAE operates under DHA Facility License No. 1143, located at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. All procedures adhere to the highest standards of clinical safety and quality assurance.
Clinical & Logistical Metadata
| Test Name | ACADS Gene (Short-Chain Acyl-CoA Dehydrogenase Deficiency) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | E71.31 |
| LOINC Code | 81305-9 |
| DHA Facility License & Laboratory Address | DHA License 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians